Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 172 entries
Sorted by: Best Match Show Resources per page
Adenosine for the treatment of sustained sinus nodal reentrant tachycardia during general anesthesia.

Journal of anesthesia

Han DG, Rosenblatt MA, Reed AP.
PMID: 28921292
J Anesth. 1995 Jun;9(2):188-191. doi: 10.1007/BF02479855.

No abstract available.

Cite
Han DG, Rosenblatt MA, Reed AP. Adenosine for the treatment of sustained sinus nodal reentrant tachycardia during general anesthesia. J Anesth. 1995;9(2):188-191doi: 10.1007/BF02479855.
Han, D. G., Rosenblatt, M. A., & Reed, A. P. (1995). Adenosine for the treatment of sustained sinus nodal reentrant tachycardia during general anesthesia. Journal of anesthesia, 9(2), 188-191. https://doi.org/10.1007/BF02479855
Han, Don G, et al. "Adenosine for the treatment of sustained sinus nodal reentrant tachycardia during general anesthesia." Journal of anesthesia vol. 9,2 (1995): 188-191. doi: https://doi.org/10.1007/BF02479855
Han DG, Rosenblatt MA, Reed AP. Adenosine for the treatment of sustained sinus nodal reentrant tachycardia during general anesthesia. J Anesth. 1995 Jun;9(2):188-191. doi: 10.1007/BF02479855. PMID: 28921292.
Copy Download .nbib Format: NLM
Somatic overgrowth associated with homozygous mutations in both MAN1B1 and SEC23A.

Cold Spring Harbor molecular case studies

Gupta S, Fahiminiya S, Wang T, Dempsey Nunez L, Rosenblatt DS, Gibson WT, Gilfix B, Bergeron JJ, Jerome-Majewska LA.
PMID: 27148587
Cold Spring Harb Mol Case Stud. 2016 May;2(3):a000737. doi: 10.1101/mcs.a000737.

Using whole-exome sequencing, we identified homozygous mutations in two unlinked genes, SEC23A c.1200G>C (p.M400I) and MAN1B1 c.1000C>T (p.R334C), associated with congenital birth defects in two patients from a consanguineous family. Patients presented with carbohydrate-deficient transferrin, tall stature, obesity, macrocephaly,...

Cite
Gupta S, Fahiminiya S, Wang T, et al. Somatic overgrowth associated with homozygous mutations in both MAN1B1 and SEC23A. Cold Spring Harb Mol Case Stud. 2016;2(3):a000737doi: 10.1101/mcs.a000737.
Gupta, S., Fahiminiya, S., Wang, T., Dempsey Nunez, L., Rosenblatt, D. S., Gibson, W. T., Gilfix, B., Bergeron, J. J., & Jerome-Majewska, L. A. (2016). Somatic overgrowth associated with homozygous mutations in both MAN1B1 and SEC23A. Cold Spring Harbor molecular case studies, 2(3), a000737. https://doi.org/10.1101/mcs.a000737
Gupta, Swati, et al. "Somatic overgrowth associated with homozygous mutations in both MAN1B1 and SEC23A." Cold Spring Harbor molecular case studies vol. 2,3 (2016): a000737. doi: https://doi.org/10.1101/mcs.a000737
Gupta S, Fahiminiya S, Wang T, Dempsey Nunez L, Rosenblatt DS, Gibson WT, Gilfix B, Bergeron JJ, Jerome-Majewska LA. Somatic overgrowth associated with homozygous mutations in both MAN1B1 and SEC23A. Cold Spring Harb Mol Case Stud. 2016 May;2(3):a000737. doi: 10.1101/mcs.a000737. PMID: 27148587; PMCID: PMC4853519.
Copy Download .nbib Format: NLM
VERTEBRATE AIR BREATHING AROSE IN FRESH WATERS AND NOT IN THE OCEANS.

Evolution; international journal of organic evolution

Graham JB, Rosenblatt RH, Gans C.
PMID: 28563741
Evolution. 1978 Jun;32(2):459-463. doi: 10.1111/j.1558-5646.1978.tb00662.x.

No abstract available.

Cite
Graham JB, Rosenblatt RH, Gans C. VERTEBRATE AIR BREATHING AROSE IN FRESH WATERS AND NOT IN THE OCEANS. Evolution. 1978;32(2):459-463doi: 10.1111/j.1558-5646.1978.tb00662.x.
Graham, J. B., Rosenblatt, R. H., & Gans, C. (1978). VERTEBRATE AIR BREATHING AROSE IN FRESH WATERS AND NOT IN THE OCEANS. Evolution; international journal of organic evolution, 32(2), 459-463. https://doi.org/10.1111/j.1558-5646.1978.tb00662.x
Graham, Jeffrey B, et al. "VERTEBRATE AIR BREATHING AROSE IN FRESH WATERS AND NOT IN THE OCEANS." Evolution; international journal of organic evolution vol. 32,2 (1978): 459-463. doi: https://doi.org/10.1111/j.1558-5646.1978.tb00662.x
Graham JB, Rosenblatt RH, Gans C. VERTEBRATE AIR BREATHING AROSE IN FRESH WATERS AND NOT IN THE OCEANS. Evolution. 1978 Jun;32(2):459-463. doi: 10.1111/j.1558-5646.1978.tb00662.x. PMID: 28563741.
Copy Download .nbib Format: NLM
"Critical Periods" in the Development of Behavior.

Science (New York, N.Y.)

Schneirla TC, Rosenblatt JS.
PMID: 17813013
Science. 1963 Mar 15;139(3559):1110-5. doi: 10.1126/science.139.3559.1110.

No abstract available.

Cite
Schneirla TC, Rosenblatt JS. "Critical Periods" in the Development of Behavior. Science. 1963;139(3559):1110-5doi: 10.1126/science.139.3559.1110.
Schneirla, T. C., & Rosenblatt, J. S. (1963). "Critical Periods" in the Development of Behavior. Science (New York, N.Y.), 139(3559), 1110-5. https://doi.org/10.1126/science.139.3559.1110
Schneirla, T C, and Rosenblatt, J S. ""Critical Periods" in the Development of Behavior." Science (New York, N.Y.) vol. 139,3559 (1963): 1110-5. doi: https://doi.org/10.1126/science.139.3559.1110
Schneirla TC, Rosenblatt JS. "Critical Periods" in the Development of Behavior. Science. 1963 Mar 15;139(3559):1110-5. doi: 10.1126/science.139.3559.1110. PMID: 17813013.
Copy Download .nbib Format: NLM
The underwriting cycle: the rule of six.

Health affairs (Project Hope)

Rosenblatt A.
PMID: 15537588
Health Aff (Millwood). 2004 Nov-Dec;23(6):103-6. doi: 10.1377/hlthaff.23.6.103.

The underwriting cycle is a thing of the past for most health insurance companies. There were six primary factors that caused the six-year pattern of the underwriting cycle for 1965-1991. These factors were claims payment cycle time, renewal dates...

Cite
Rosenblatt A. The underwriting cycle: the rule of six. Health Aff (Millwood). 2004;23(6):103-6doi: 10.1377/hlthaff.23.6.103.
Rosenblatt, A. (2004). The underwriting cycle: the rule of six. Health affairs (Project Hope), 23(6), 103-6. https://doi.org/10.1377/hlthaff.23.6.103
Rosenblatt, Alice. "The underwriting cycle: the rule of six." Health affairs (Project Hope) vol. 23,6 (2004): 103-6. doi: https://doi.org/10.1377/hlthaff.23.6.103
Rosenblatt A. The underwriting cycle: the rule of six. Health Aff (Millwood). 2004 Nov-Dec;23(6):103-6. doi: 10.1377/hlthaff.23.6.103. PMID: 15537588.
Copy Download .nbib Format: NLM
Diagnosis and treatment of chronic rhinosinusitis: focus on intranasal Amphotericin B.

Therapeutics and clinical risk management

Kern EB, Sherris D, Stergiou AM, Katz LM, Rosenblatt LC, Ponikau J.
PMID: 18360640
Ther Clin Risk Manag. 2007 Jun;3(2):319-25. doi: 10.2147/tcrm.2007.3.2.319.

Chronic rhinosinusitis (CRS) is a chronic disease that affects 14.2% of the US adult population. Despite being widespread, little is known about the etiology of CRS. Treatment has been symptomatic and focused on relieving symptoms. Recent investigations into causes...

Cite
Kern EB, Sherris D, Stergiou AM, et al. Diagnosis and treatment of chronic rhinosinusitis: focus on intranasal Amphotericin B. Ther Clin Risk Manag. 2007;3(2):319-25doi: 10.2147/tcrm.2007.3.2.319.
Kern, E. B., Sherris, D., Stergiou, A. M., Katz, L. M., Rosenblatt, L. C., & Ponikau, J. (2007). Diagnosis and treatment of chronic rhinosinusitis: focus on intranasal Amphotericin B. Therapeutics and clinical risk management, 3(2), 319-25. https://doi.org/10.2147/tcrm.2007.3.2.319
Kern, Eugene B, et al. "Diagnosis and treatment of chronic rhinosinusitis: focus on intranasal Amphotericin B." Therapeutics and clinical risk management vol. 3,2 (2007): 319-25. doi: https://doi.org/10.2147/tcrm.2007.3.2.319
Kern EB, Sherris D, Stergiou AM, Katz LM, Rosenblatt LC, Ponikau J. Diagnosis and treatment of chronic rhinosinusitis: focus on intranasal Amphotericin B. Ther Clin Risk Manag. 2007 Jun;3(2):319-25. doi: 10.2147/tcrm.2007.3.2.319. PMID: 18360640; PMCID: PMC1936313.
Copy Download .nbib Format: NLM
A phase I trial of outpatient weekly docetaxel and concurrent radiation therapy for stage III unresectable non small-cell lung cancer: a Vanderbilt Cancer Center Affiliate Network (VCCAN) Trial.

Clinical lung cancer

Choy H, DeVore RF, Hande KR, Porter LL, Rosenblatt PA, Slovis B, Laporte K, Shyr Y, Johnson DH.
PMID: 14725740
Clin Lung Cancer. 2000 Apr;1:S27-31. doi: 10.3816/clc.2000.s.006.

Docetaxel has demonstrated activity as a radiosensitizer in numerous preclinical studies, probably due to its role as a cell cycle synchronizer for the G2/M radiosensitive phase of the cell cycle. We conducted a phase I trial to determine the...

Cite
Choy H, DeVore RF, Hande KR, et al. A phase I trial of outpatient weekly docetaxel and concurrent radiation therapy for stage III unresectable non small-cell lung cancer: a Vanderbilt Cancer Center Affiliate Network (VCCAN) Trial. Clin Lung Cancer. 2000;1:S27-31doi: 10.3816/clc.2000.s.006.
Choy, H., DeVore, R. F., Hande, K. R., Porter, L. L., Rosenblatt, P. A., Slovis, B., Laporte, K., Shyr, Y., & Johnson, D. H. (2000). A phase I trial of outpatient weekly docetaxel and concurrent radiation therapy for stage III unresectable non small-cell lung cancer: a Vanderbilt Cancer Center Affiliate Network (VCCAN) Trial. Clinical lung cancer, 1S27-31. https://doi.org/10.3816/clc.2000.s.006
Choy, H, et al. "A phase I trial of outpatient weekly docetaxel and concurrent radiation therapy for stage III unresectable non small-cell lung cancer: a Vanderbilt Cancer Center Affiliate Network (VCCAN) Trial." Clinical lung cancer vol. 1 (2000): S27-31. doi: https://doi.org/10.3816/clc.2000.s.006
Choy H, DeVore RF, Hande KR, Porter LL, Rosenblatt PA, Slovis B, Laporte K, Shyr Y, Johnson DH. A phase I trial of outpatient weekly docetaxel and concurrent radiation therapy for stage III unresectable non small-cell lung cancer: a Vanderbilt Cancer Center Affiliate Network (VCCAN) Trial. Clin Lung Cancer. 2000 Apr;1:S27-31. doi: 10.3816/clc.2000.s.006. PMID: 14725740.
Copy Download .nbib Format: NLM
Kinetics and products of hydrolysis of 1,2-dibromo-3-chloropropane.

Environmental science & technology

Burlinson NE, Lee LA, Rosenblatt DH.
PMID: 22284208
Environ Sci Technol. 1982 Sep 01;16(9):627-32. doi: 10.1021/es00103a018.

No abstract available.

Cite
Burlinson NE, Lee LA, Rosenblatt DH. Kinetics and products of hydrolysis of 1,2-dibromo-3-chloropropane. Environ Sci Technol. 1982;16(9):627-32doi: 10.1021/es00103a018.
Burlinson, N. E., Lee, L. A., & Rosenblatt, D. H. (1982). Kinetics and products of hydrolysis of 1,2-dibromo-3-chloropropane. Environmental science & technology, 16(9), 627-32. https://doi.org/10.1021/es00103a018
Burlinson, N E, et al. "Kinetics and products of hydrolysis of 1,2-dibromo-3-chloropropane." Environmental science & technology vol. 16,9 (1982): 627-32. doi: https://doi.org/10.1021/es00103a018
Burlinson NE, Lee LA, Rosenblatt DH. Kinetics and products of hydrolysis of 1,2-dibromo-3-chloropropane. Environ Sci Technol. 1982 Sep 01;16(9):627-32. doi: 10.1021/es00103a018. PMID: 22284208.
Copy Download .nbib Format: NLM
Maintaining manager mental wellness.

Nursing management

Rosenblatt CL, Davis MS.
PMID: 19901759
Nurs Manage. 2009 Nov;40(11):52-3. doi: 10.1097/01.NUMA.0000363872.08198.bf.

No abstract available.

Cite
Rosenblatt CL, Davis MS. Maintaining manager mental wellness. Nurs Manage. 2009;40(11):52-3doi: 10.1097/01.NUMA.0000363872.08198.bf.
Rosenblatt, C. L., & Davis, M. S. (2009). Maintaining manager mental wellness. Nursing management, 40(11), 52-3. https://doi.org/10.1097/01.NUMA.0000363872.08198.bf
Rosenblatt, Carolyn L, and Davis, Mikol S. "Maintaining manager mental wellness." Nursing management vol. 40,11 (2009): 52-3. doi: https://doi.org/10.1097/01.NUMA.0000363872.08198.bf
Rosenblatt CL, Davis MS. Maintaining manager mental wellness. Nurs Manage. 2009 Nov;40(11):52-3. doi: 10.1097/01.NUMA.0000363872.08198.bf. PMID: 19901759.
Copy Download .nbib Format: NLM
[In Process Citation].

The Journal of clinical and aesthetic dermatology

Keri JE, Rosenblatt AE.
PMID: 21203358
J Clin Aesthet Dermatol. 2008 Sep;1(3):22-6.

Diet plays an important role in the pathogenesis of a variety of diseases. Recently, there has been an increasing interest in the role of diet in the development of common skin conditions such as acne and rosacea. The association...

Cite
Keri JE, Rosenblatt AE. [In Process Citation]. J Clin Aesthet Dermatol. 2008;1(3):22-6
Keri, J. E., & Rosenblatt, A. E. (2008). [In Process Citation]. The Journal of clinical and aesthetic dermatology, 1(3), 22-6.
Keri, Jonette E, and Rosenblatt, Adena E. "[In Process Citation]." The Journal of clinical and aesthetic dermatology vol. 1,3 (2008): 22-6.
Keri JE, Rosenblatt AE. [In Process Citation]. J Clin Aesthet Dermatol. 2008 Sep;1(3):22-6. PMID: 21203358; PMCID: PMC3013591.
Copy Download .nbib Format: NLM
A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)(a).

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Baron EJ, Miller JM, Weinstein MP, Richter SS, Gilligan PH, Thomson RB, Bourbeau P, Carroll KC, Kehl SC, Dunne WM, Robinson-Dunn B, Schwartzman JD, Chapin KC, Snyder JW, Forbes BA, Patel R, Rosenblatt JE, Pritt BS.
PMID: 23845951
Clin Infect Dis. 2013 Aug;57(4):e22-e121. doi: 10.1093/cid/cit278. Epub 2013 Jul 10.

The critical role of the microbiology laboratory in infectious disease diagnosis calls for a close, positive working relationship between the physician and the microbiologists who provide enormous value to the health care team. This document, developed by both laboratory...

Cite
Baron EJ, Miller JM, Weinstein MP, et al. A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)(a). Clin Infect Dis. 2013;57(4):e22-e121doi: 10.1093/cid/cit278.
Baron, E. J., Miller, J. M., Weinstein, M. P., Richter, S. S., Gilligan, P. H., Thomson, R. B., Bourbeau, P., Carroll, K. C., Kehl, S. C., Dunne, W. M., Robinson-Dunn, B., Schwartzman, J. D., Chapin, K. C., Snyder, J. W., Forbes, B. A., Patel, R., Rosenblatt, J. E., & Pritt, B. S. (2013). A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)(a). Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 57(4), e22-e121. https://doi.org/10.1093/cid/cit278
Baron, Ellen Jo, et al. "A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)(a)." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America vol. 57,4 (2013): e22-e121. doi: https://doi.org/10.1093/cid/cit278
Baron EJ, Miller JM, Weinstein MP, Richter SS, Gilligan PH, Thomson RB, Bourbeau P, Carroll KC, Kehl SC, Dunne WM, Robinson-Dunn B, Schwartzman JD, Chapin KC, Snyder JW, Forbes BA, Patel R, Rosenblatt JE, Pritt BS. A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)(a). Clin Infect Dis. 2013 Aug;57(4):e22-e121. doi: 10.1093/cid/cit278. Epub 2013 Jul 10. PMID: 23845951; PMCID: PMC3719886.
Copy Download .nbib Format: NLM
Effects of a New Nano-Silver Fluoride-Containing Dentifrice on Demineralization of Enamel and .

International journal of dentistry

Teixeira JA, Silva AVCE, Dos Santos Júnior VE, de Melo Júnior PC, Arnaud M, Lima MG, Flores MAP, Stamford TCM, Dias Pereira JR, Ribeiro Targino AG, Galembeck A, Rosenblatt A.
PMID: 29853891
Int J Dent. 2018 May 08;2018:1351925. doi: 10.1155/2018/1351925. eCollection 2018.

An experimental dentifrice containing nano-silver fluoride (NSF) and a sodium fluoride (NaF) toothpaste were tested

Cite
Teixeira JA, Silva AVCE, Dos Santos Júnior VE, et al. Effects of a New Nano-Silver Fluoride-Containing Dentifrice on Demineralization of Enamel and . Int J Dent. 2018;2018:1351925doi: 10.1155/2018/1351925.
Teixeira, J. A., Silva, A. V. C. E., Dos Santos Júnior, V. E., de Melo Júnior, P. C., Arnaud, M., Lima, M. G., Flores, M. A. P., Stamford, T. C. M., Dias Pereira, J. R., Ribeiro Targino, A. G., Galembeck, A., & Rosenblatt, A. (2018). Effects of a New Nano-Silver Fluoride-Containing Dentifrice on Demineralization of Enamel and . International journal of dentistry, 20181351925. https://doi.org/10.1155/2018/1351925
Teixeira, Joás Araújo, et al. "Effects of a New Nano-Silver Fluoride-Containing Dentifrice on Demineralization of Enamel and ." International journal of dentistry vol. 2018 (2018): 1351925. doi: https://doi.org/10.1155/2018/1351925
Teixeira JA, Silva AVCE, Dos Santos Júnior VE, de Melo Júnior PC, Arnaud M, Lima MG, Flores MAP, Stamford TCM, Dias Pereira JR, Ribeiro Targino AG, Galembeck A, Rosenblatt A. Effects of a New Nano-Silver Fluoride-Containing Dentifrice on Demineralization of Enamel and . Int J Dent. 2018 May 08;2018:1351925. doi: 10.1155/2018/1351925. eCollection 2018. PMID: 29853891; PMCID: PMC5964412.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 172 entries